RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medica Sur SAB de CV Stock

Medica Sur SAB de CV P/S 2024

Medica Sur SAB de CV P/S

0.66

Ticker

MEDICAB.MX

ISIN

MXP510121215

WKN

A1JHBB

As of Aug 25, 2024, Medica Sur SAB de CV's P/S ratio stood at 0.66, a -37.74% change from the 1.06 P/S ratio recorded in the previous year.

The Medica Sur SAB de CV P/S history

Medica Sur SAB de CV Aktienanalyse

What does Medica Sur SAB de CV do?

Medica Sur SAB de CV is a leading Mexican healthcare company that was originally founded in 1982. Headquartered in Mexico City, Medica Sur operates hospitals, medical clinics, laboratories, and diagnostic centers throughout the country. The company aims to provide comprehensive and high-quality healthcare and has earned an outstanding reputation through its innovative medical technology and expertise. The core business of Medica Sur includes the operation of seven hospitals and clinical facilities in various parts of the country. These facilities provide medical services in general medicine, internal medicine, neurology, oncology, gynecology, urology, pediatrics, ophthalmology, and clinical psychiatry. The company also operates its own laboratory and diagnostic center, where a wide range of tests are performed, including X-rays and CT scans, blood tests, and biopsy examinations. Medica Sur also has a subsidiary called Hospitales Angeles, which specializes in cosmetic surgery. These facilities offer a wide range of beauty treatments, including liposuction, breast augmentation, facelifts, and Botox injections. Another important business area for Medica Sur is education and research. The company operates a prestigious training program for medical professionals such as nurses, specialists, and general practitioners. Furthermore, Medica Sur is active in medical research and invests in innovative technologies and scientific developments aimed at improving the quality and effectiveness of medical care. One of Medica Sur's biggest innovations is the use of robotics in surgery. The company utilizes robots that can respond to the surgeon's movements, thereby enabling higher precision in performing operations. The use of this technology has contributed to the advancement of surgery and opened up new treatment options for patients. Overall, Medica Sur's business model is designed to provide comprehensive and high-quality healthcare in Mexico tailored to the needs and expectations of patients. The company aims to be a leading healthcare company that utilizes innovative technologies and top-notch expertise to improve people's lives. Medica Sur SAB de CV ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Medica Sur SAB de CV's P/S Ratio

Medica Sur SAB de CV's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Medica Sur SAB de CV's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Medica Sur SAB de CV's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Medica Sur SAB de CV’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Medica Sur SAB de CV stock

What is the price-to-earnings ratio of Medica Sur SAB de CV?

The price-earnings ratio of Medica Sur SAB de CV is currently 0.66.

How has the price-earnings ratio of Medica Sur SAB de CV changed compared to last year?

The price-to-earnings ratio of Medica Sur SAB de CV has increased by -37.74% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Medica Sur SAB de CV high compared to other companies?

Yes, the price-to-earnings ratio of Medica Sur SAB de CV is high compared to other companies.

How does an increase in the price-earnings ratio of Medica Sur SAB de CV affect the company?

An increase in the price-earnings ratio of Medica Sur SAB de CV would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Medica Sur SAB de CV affect the company?

A decrease in the price-earnings ratio of Medica Sur SAB de CV would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Medica Sur SAB de CV?

Some factors that influence the price-earnings ratio of Medica Sur SAB de CV are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Medica Sur SAB de CV pay?

Over the past 12 months, Medica Sur SAB de CV paid a dividend of 13.06 MXN . This corresponds to a dividend yield of about 37.65 %. For the coming 12 months, Medica Sur SAB de CV is expected to pay a dividend of 13.06 MXN.

What is the dividend yield of Medica Sur SAB de CV?

The current dividend yield of Medica Sur SAB de CV is 37.65 %.

When does Medica Sur SAB de CV pay dividends?

Medica Sur SAB de CV pays a quarterly dividend. This is distributed in the months of June, October, June, June.

How secure is the dividend of Medica Sur SAB de CV?

Medica Sur SAB de CV paid dividends every year for the past 4 years.

What is the dividend of Medica Sur SAB de CV?

For the upcoming 12 months, dividends amounting to 13.06 MXN are expected. This corresponds to a dividend yield of 37.65 %.

In which sector is Medica Sur SAB de CV located?

Medica Sur SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medica Sur SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medica Sur SAB de CV from 5/16/2024 amounting to 1.5 MXN, you needed to have the stock in your portfolio before the ex-date on 5/14/2024.

When did Medica Sur SAB de CV pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of Medica Sur SAB de CV in the year 2023?

In the year 2023, Medica Sur SAB de CV distributed 10.485 MXN as dividends.

In which currency does Medica Sur SAB de CV pay out the dividend?

The dividends of Medica Sur SAB de CV are distributed in MXN.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medica Sur SAB de CV

Our stock analysis for Medica Sur SAB de CV Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medica Sur SAB de CV Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.